Caitlin Cameron
Amministratore Delegato presso Otonexus Medical Technologies, Inc.
Profilo
Caitlin Cameron is currently the Chairman, President & Chief Executive Officer at Otonexus Medical Technologies, Inc. since 2012 and also serves as the Director at Washington Biotechnology & Biomedical Association since 2014.
Previously, she worked as the Chief Executive Officer at Presage Biosciences, Inc.
Posizioni attive di Caitlin Cameron
Società | Posizione | Inizio |
---|---|---|
Washington Biotechnology & Biomedical Association | Direttore/Membro del Consiglio | 01/07/2014 |
Otonexus Medical Technologies, Inc.
Otonexus Medical Technologies, Inc. Medical SpecialtiesHealth Technology Otonexus Medical Technologies, Inc. is a holding company engages in health care industry. The firm designs, develops, and commercializes an ultrasound medical device that diagnoses middle ear infections in children and adults. The company was founded by Gerge A. Gates and Mark A. Moehring and is headquartered in Seattle, WA. | Amministratore Delegato | 01/01/2012 |
Precedenti posizioni note di Caitlin Cameron
Società | Posizione | Fine |
---|---|---|
Presage Biosciences, Inc.
Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Presage Biosciences, Inc.
Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Health Technology |
Washington Biotechnology & Biomedical Association | |
Otonexus Medical Technologies, Inc.
Otonexus Medical Technologies, Inc. Medical SpecialtiesHealth Technology Otonexus Medical Technologies, Inc. is a holding company engages in health care industry. The firm designs, develops, and commercializes an ultrasound medical device that diagnoses middle ear infections in children and adults. The company was founded by Gerge A. Gates and Mark A. Moehring and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Caitlin Cameron